Among the biggest challenges faced by the psychedelics industry is the stigma that surrounds it. "The anti-drug marketing of the past decades was highly effective, and so now when psychedelics are ...
Entheon Biomedical is a biotech R&D company developing a portfolio of Dimethyltryptamine (DMT) based psychedelic therapeutic products for treating addiction and substance use disorders.CEO Timothy Ko ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results